4D Molecular Therapeutics, Inc. — SC 13G Filings
11 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by 4D Molecular Therapeutics, Inc. (FDMT), sorted by most recent first. Each row links to the full filing on EdgarLookup. 4D Molecular Therapeutics, Inc. has filed 11 SC 13G documents with the SEC since 2015. To view all SEC filings by 4D Molecular Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
POS AM
POSASR
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0000932471-24-000236 | Nov 4, 2024 | — |
| SC 13G | SC 13G | 0001104659-23-068069 | Jun 5, 2023 | — |
| SC 13G | SC 13G | 0001104659-23-060800 | May 15, 2023 | — |
| SC 13G | — | 0000834237-22-007098 | Feb 4, 2022 | — |
| SC 13G | — | 0001172661-21-002113 | Nov 4, 2021 | — |
| SC 13G | THE SCHEDULE 13G | 0000921895-21-001775 | Jul 6, 2021 | — |
| SC 13G | SC 13G | 0001193125-21-042200 | Feb 16, 2021 | — |
| SC 13G | SC 13G | 0001193125-21-042194 | Feb 16, 2021 | — |
| SC 13G | — | 0000315066-21-000816 | Feb 8, 2021 | — |
| SC 13G | SCHEDULE 13G | 0001104659-20-139059 | Dec 23, 2020 | — |
| SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-20-011460 | Dec 21, 2020 | — |